أعرض في EDS

Supplementary Data from Antitumor Activity of BIBF 1120, a Triple Angiokinase Inhibitor, and Use of VEGFR2+pTyr+ Peripheral Blood Leukocytes as a Pharmacodynamic Biomarker In Vivo

التفاصيل البيبلوغرافية
العنوان:	Supplementary Data from Antitumor Activity of BIBF 1120, a Triple Angiokinase Inhibitor, and Use of VEGFR2+pTyr+ Peripheral Blood Leukocytes as a Pharmacodynamic Biomarker In Vivo
المؤلفون:	Kazuto Nishio, Masatoshi Kudo, Nagahiro Saijo, Yoshihiko Fujita, Marco A. De Velasco, Keiichi Aomatsu, Daisuke Tamura, Kazuko Matsumoto, Hiroyasu Kaneda, Kazuko Sakai, Kazuyuki Furuta, Tomoyuki Nagai, Kaoru Tanaka, Tokuzo Arao, Kanae Kudo
بيانات النشر:	American Association for Cancer Research (AACR), 2023.
سنة النشر:	2023
الوصف:	Supplementary Figures S1-S3; Supplementary Tables S1-S2.
DOI:	10.1158/1078-0432.22442247.v1
URL الوصول:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8657c33cceff5c7b0f45864c4b0c6fa https://doi.org/10.1158/1078-0432.22442247.v1
Rights:	OPEN
رقم الانضمام:	edsair.doi.dedup.....a8657c33cceff5c7b0f45864c4b0c6fa
قاعدة البيانات:	OpenAIRE

الوصف
DOI:	10.1158/1078-0432.22442247.v1